Toward the Rational Design of P53-Stabilizing Drugs: Probing the Surface of the Oncogenic Y220C Mutant.
Basse, N., Kaar, J.L., Settanni, G., Joerger, A.C., Rutherford, T.J., Fersht, A.R.(2010) Chem Biol 17: 46
- PubMed: 20142040 
- DOI: 10.1016/j.chembiol.2009.12.011
- Primary Citation of Related Structures:  
2X0U, 2X0V, 2X0W - PubMed Abstract: 
The p53 cancer mutation Y220C induces formation of a cavity on the protein's surface that can accommodate stabilizing small molecules. We combined fragment screening and molecular dynamics to assess the druggability of p53-Y220C and map ligand interaction sites within the mutational cavity ...